As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of sleep therapy devices in the U.S., competitor ResMed, meanwhile, is ramping up its product ...
SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential ...
As competitor Philips continues to grapple with the effects of its long-standing recall of continuous positive airway pressure (CPAP) machines and other respiratory devices, ResMed is now issuing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results